Compare GNSS & ONCY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | GNSS | ONCY |
|---|---|---|
| Founded | 1992 | 1998 |
| Country | United States | Canada |
| Employees | N/A | N/A |
| Industry | Consumer Electronics/Appliances | Pharmaceuticals and Biotechnology |
| Sector | Consumer Staples | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 101.7M | 94.0M |
| IPO Year | 1996 | 2002 |
| Metric | GNSS | ONCY |
|---|---|---|
| Price | $1.90 | $0.99 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 2 | 4 |
| Target Price | $4.75 | ★ $7.33 |
| AVG Volume (30 Days) | 131.3K | ★ 1.1M |
| Earning Date | 01-01-0001 | 01-01-0001 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 44.44 | N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $26,306,790.00 | N/A |
| Revenue This Year | $78.94 | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | ★ 29.50 | N/A |
| 52 Week Low | $1.46 | $0.33 |
| 52 Week High | $2.70 | $1.51 |
| Indicator | GNSS | ONCY |
|---|---|---|
| Relative Strength Index (RSI) | 47.07 | 47.79 |
| Support Level | $1.87 | $0.94 |
| Resistance Level | $2.11 | $1.08 |
| Average True Range (ATR) | 0.10 | 0.07 |
| MACD | 0.00 | -0.01 |
| Stochastic Oscillator | 48.90 | 22.65 |
Genasys Inc is a provider of Protective Communication solutions, including Genasys Protect software platform and Long Range Acoustic Device (LRAD). Its software platform receives information from variety of sensors and Internet-of-Things (IoT) inputs to collect real-time information on developing and active emergency situations. Genasys uses this information to create and disseminate alerts, warnings, notifications, and instructions through multiple channels before, during, and after public safety and enterprise threats, critical events, and other crisis situations. The Company operates in two business segments: Hardware and Software and its markets are North and South America, Europe, Middle East and Asia. Key revenue is generated from Hardware.
Oncolytics Biotech Inc is a clinical-stage biopharmaceutical company. The company is focused on the discovery and development of pharmaceutical products for the treatment of cancers that have not been treated with therapeutics. It is developing pelareorep, an immunotherapeutic agent that improves the ability of the immune system to fight cancer, making tumors more susceptible to a broad range of oncology treatments. The other projects in the company's pipeline include Bracelet-1 for the treatment of Breast Cancer, Goblet cohort-1, and Goblet cohort-5 for the treatment of Gastro-Intestinal Cancer among others.